#USA #Werfen #Bedford #IMV ServiceTrak #Coagulation

Werfen Wins 2026 IMV ServiceTrak Awards

In a significant achievement for the medical diagnostics sector, Werfen has been awarded all three categories at the 2026 IMV ServiceTrak™ Clinical Laboratory Awards in Coagulation. Recognizing the brand for Best Customer Satisfaction, Best System Performance, and Best Service, these awards highlight the company's ongoing commitment to quality and excellence in the field of hemostasis.

This recognition is based on independent feedback gathered from clinical laboratory professionals throughout the United States, representing nearly 2,000 testing locations and over 4,000 instruments. Each year, the ServiceTrak program benchmark customer satisfaction, system performance, and service excellence in various medical diagnostic modalities.

Bill Crandell, Werfen's Vice President of North America Commercial Operations, expressed pride in receiving these awards, stating, "This achievement is a testament to the dedication and specialization of our entire team—from the individuals who design and manufacture innovative solutions to those who support our customers daily. Together, this commitment enables us to fulfill our purpose of Powering Patient Care."

Richa Singh, VP of Strategic Insights at IMV, emphasized the importance of these awards, stating, "Winning the ServiceTrak Best of Customer Satisfaction, Best System Performance and Best Service awards reflects genuine feedback from clinical lab professionals who use Werfen’s systems every day. These awards are grounded in independent, data-driven research, which makes them one of the most credible benchmarks in the industry."

About Werfen's Hemostasis Solutions

Werfen’s Complete Hemostasis Solution encompasses advanced in vitro diagnostic systems, reagents, and automation tailored for diagnosing and managing thrombotic and bleeding disorders. The ACL TOP® Family 70 Series represents a standardized family of systems dedicated to Hemostasis testing. Furthermore, the comprehensive HemosIL® portfolio offers routine and specialty reagents for general screening and disease-state management. To enhance efficiency, the HemoCell® Specialized Lab Automation is customized for each laboratory, optimizing testing workflows. Additionally, the HemoHub® Intelligent Data Manager facilitates the centralized management of Werfen Hemostasis systems.

The company’s award-winning service and support teams ensure that customers achieve optimal instrument operation, providing training and 24/7 technical assistance to tackle challenges as they arise.

History and Significance of IMV ServiceTrak Awards

IMV, part of the Science and Medicine Group, conducts an annual survey of clinical laboratory professionals, providing valuable insights into service trends in the diagnostic realm. The ServiceTrak initiative has been regarded as an industry benchmark for over 25 years, determining which manufacturers excel based on specific criteria such as customer satisfaction and service performance.

The awards recognize the top provider in various modalities across three categories: Best of Customer Satisfaction, Best of System Performance, and Best of Service. This year, Werfen’s consistent focus on innovation and customer-centric practices solidified its status as a leader in the coagulation sector.

About Werfen

Founded in 1966, Werfen is a global developer and manufacturer of specialized diagnostic instruments, reagents, automation workcells, and data management solutions primarily utilized in hospitals and independent laboratories. The company focuses on clinical areas such as Hemostasis, Acute Care, Transfusion, Autoimmunity, and Transplant. Their notable Hemostasis portfolio includes products like the ACL TOP® Family, the award-winning ACL Elite® Pro, HemoCell, and the smart HemoHub data manager, along with an extensive range of HemosIL reagents.

Werfen’s commitment to excellence and innovation continues to drive advancements in patient care and diagnostic efficiency within the medical community.